Clinical trial Recruiting at 1 site Interventional

Carbohydrate loading for diabetic patients undergoing heart surgery

Official title: Efficacy of Carbohydrate Loading in Diabetic Type 2 Patients Undergoing CABG Surgery on CPB

Run by Damascus University · NCT06951308 · Data updated 2026-11-12

This study is testing if eating carbohydrates before heart surgery can help people with type 2 diabetes recover better and have fewer complications.

Quick facts

Study typeInterventional
SexAll
Enrollment50 (estimated)
SponsorDamascus University
Academic / other
Locations1 site (Damascus)
StatusRecruiting
StartedApril 1, 2025
Main results expectedApril 30, 2026
Study endsDecember 31, 2026
Registry record updatedSeptember 1, 2026
Trial IDNCT06951308 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are diabetic type 2 patients scheduled for isolated on-pump coronary artery bypass surgery.

Probably not a fit

Patients with type 1 diabetes or those undergoing other cardiac surgeries may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial evaluates the effects of carbohydrate loading on diabetic type 2 patients undergoing coronary artery bypass grafting (CABG) surgery. Patients will be randomly assigned to receive either carbohydrate loading two hours before surgery or follow a standard fasting protocol. The study aims to assess the impact of carbohydrate loading on insulin resistance, clinical outcomes such as infection rates and ICU stay duration, and changes in inflammatory markers. By focusing on this specific population, the trial seeks to fill the knowledge gap regarding the efficacy of carbohydrate loading in diabetic patients.

Why it matters

Potential benefit: If successful, this approach could improve recovery outcomes and reduce complications for diabetic patients undergoing heart surgery.

How similar studies have gone: While carbohydrate loading has shown benefits in non-diabetic patients, its efficacy in diabetic type 2 patients undergoing CABG is less understood, making this a novel investigation.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

All diabetic type 2 patients undergoing isolated on-pump coronary artery bypass surgery.

Exclusion Criteria:

* Missing data.
* Patients outside the study period.
* Patients undergoing other cardiac surgeries.
* Patients diagnosed with type 1 diabetes mellitus.

Where it's running

  • Damascus University Cardiac Surgery Hospital
    Damascus, Syria
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.